SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-042972
Filing Date
2024-04-09
Accepted
2024-04-09 16:10:23
Documents
11
Period of Report
2024-04-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K fusn-20240409.htm   iXBRL 8-K 43160
  Complete submission text file 0000950170-24-042972.txt   168871

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fusn-20240409.xsd EX-101.SCH 32041
14 EXTRACTED XBRL INSTANCE DOCUMENT fusn-20240409_htm.xml XML 4873
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39344 | Film No.: 24832825
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)